OTLK
Outlook Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.49
+0.98%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 1.51x
- P/S forward
- 2.72x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -11.55x
- Price / sales
- -103.18x
- Price / cash flow
- -2.10x
Enterprise value
- Enterprise value
- $127.2M
- EV / sales
- -109.36x
- EV / EBITDA
- -2.04x
- EV / EBIT
- -2.29x
- Market cap
- $120.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026